Pimodivir

DB14974InvestigationalSmall molecule

Pimodivir is under investigation in clinical trial NCT02658825 (A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants).

Chemical structure of Pimodivir
Formula / weight
C20H19F2N5O2 · 399.402 g/mol (avg)
Also known as
JNJ-63623872

Resolves to

Compound
UNIIDFC121MXC3CAS1629869-44-8ChEMBLCHEMBL3318007
Structure
InChIKeyJGPXDNKSIXAZEQ-SBBZOCNPSA-NSMILESOC(=O)[C@H]1C2CCC(CC2)[C@@H]1NC1=NC(=NC=C1F)C1=CNC2=NC=C(F)C=C12

What you can answer from here — as of April 23, 2025

11Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Pimodivir, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In